Become A Featured Company

Medican Enterprises Signs LOI to Acquire 50% Stake in Canadian Firm Seeking MMPR

Ryan Allway

March 27th, 2014

News, Top Story

Medican Enterprises, Inc. (OTC: MDCN), a bio-pharmaceutical company in the emerging global medical marijuana industry, has made a lot of progress building its footprint in the cannabis industry. For instance, in the first quarter alone the company added a former New Mexico Governor to its Board of Directors and a cannabis industry veteran David Tobias joined its Board of Advisors rounding out its team.

This week, the company announced a letter of intent to purchase a 50% stake in Canadian firm that has applied for a MMPR license. International Herbs Medical Marijuana Ltd. was founded by the owners of Western Canada’s largest fresh herb grower, importer, distributor and a leading specialty herb producer in North American, providing significant expertise in a highly related industry.

Investors may want to take a closer look at Medican Enterprises given these recent developments. Successful acquisition of an MMPR license could yield significant revenue over the coming quarters as the program gears up for an April 1st launch.

Read the entire press release discussing the LOI here:

Medican Enterprises, Inc. (MDCN) a bio-pharmaceutical company in the emerging global medical marijuana industry is pleased to announce its wholly owned subsidiary Medican Systems Inc. has signed a letter of intent (LOI) to purchase 50% of International Herbs Medical Marijuana Ltd. (“IHMML”). IHMML has applied as a licensed producer under the Health Canada, Marijuana for Medical Purposes Regulations program.

IHMML was founded by the owners of International Herbs Ltd (“IHL”), Western Canada’s largest fresh herb grower, importer, distributor and a leading specialty herbal produce grower in North America; and the Monark Group (“Monark”), a full service provider of marketing, IT solutions and outsourced service centers focused on the pharmaceutical industry. Under the terms of the agreement the management team of IHMML would stay intact and will continue to provide day to day management services.

IHMML has entered into contracts for the purchase of two facilities in New Brunswick, Canada. The first building is 393,000 square feet with 300,000 square foot growing space. The second is a 273,000 square foot facility with potential to expand to a total of 600,000 sq ft.

In addition to the real estate purchase, IHMML will build a direct sales channel and enable Consumers to purchase products via the company’s website, enhanced through SEO; and will work to develop the Medical Professional Channel working closely with Doctors, Nurse Practitioners and Naturopaths to provide educational and awareness training to recommend the high grade products that IHMML will produce.

“This acquisition would be an important step in the company’s strategic plan to design, construct and operate Medical Marijuana Cultivation and Research Centers across Canada,” said Ken Williams, CEO of Medican Enterprises. “Medican Enterprises benefits from immediate access to a large scale industrial facility and an established marketing and distribution channel. It is a critical time in the Company’s development and as one of the first movers into the commercial production of medical marijuana, Medican is positioned to swiftly scale its operations resulting in a very steady revenue base.”

“In a short amount of time Medican Enterprises has demonstrated a strategic and best-in class approach to the medical marijuana industry,” said Kevin Coft, CEO of IHMML. “We are excited to be joining the Medican family and are looking forward to a successful partnership.” The definitive agreement is subject to certain customary terms and conditions and is expected to be executed on March 28, 2014.

About Medican Enterprises Inc.

Medican Enterprises is a bio-pharmaceutical company focused on developing, distributing and marketing pharmaceutical grade cannabis to the emerging global medical marijuana market. It’s wholly owned subsidiary Medican Systems Inc. is an industry leader in the design, construction and operation of Medical Marijuana and Cultivation Centers across Canada. Traded on the OTCBB, Medican drives shareholder value through its scalable business model and commitment to scientific research, operational excellence and regulatory compliance. For more information visit: www.medicaninc.com.

Forward-Looking and Cautionary Statements

Certain statements contained herein contain “forward-looking statements” within the meaning of Section 27A of Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934. Statements in this press release that are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medican Enterprises Inc. to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Given these uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements. Medican Enterprises Inc. disclaims any obligation to update or to announce publicly the results of any revision of the forward-looking statements contained or incorporated by reference herein to reflect future events or developments. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in the reports and other documents we file with the SEC, available at www.sec.gov.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

Network Partners

Follow Us on Social Media

LinkedIn

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading